Compare HP & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HP | BHC |
|---|---|---|
| Founded | 1920 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.2B |
| IPO Year | N/A | N/A |
| Metric | HP | BHC |
|---|---|---|
| Price | $29.88 | $6.94 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 11 | 2 |
| Target Price | ★ $25.27 | $9.00 |
| AVG Volume (30 Days) | 1.7M | ★ 3.1M |
| Earning Date | 11-17-2025 | 10-29-2025 |
| Dividend Yield | ★ 3.35% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.97 |
| Revenue | $3,746,013,000.00 | ★ $10,029,000,000.00 |
| Revenue This Year | $8.54 | $6.81 |
| Revenue Next Year | $3.52 | $4.11 |
| P/E Ratio | ★ N/A | $7.17 |
| Revenue Growth | ★ 35.89 | 5.86 |
| 52 Week Low | $14.65 | $4.25 |
| 52 Week High | $37.30 | $8.69 |
| Indicator | HP | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 70.14 | 58.28 |
| Support Level | $25.81 | $6.14 |
| Resistance Level | $30.46 | $7.55 |
| Average True Range (ATR) | 1.21 | 0.29 |
| MACD | 0.20 | 0.11 |
| Stochastic Oscillator | 92.35 | 67.99 |
Helmerich & Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.